- Home
- ADVB vs BOLT Comparison
ADVB vs BOLT Comparison
Compare ADVB & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- BOLT
- Stock Information
- Founded
- ADVB 2014
- BOLT 2015
- Country
- ADVB United States
- BOLT United States
- Employees
- ADVB N/A
- BOLT N/A
- Industry
- ADVB Medical Specialities
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- ADVB Health Care
- BOLT Health Care
- Exchange
- ADVB Nasdaq
- BOLT Nasdaq
- Market Cap
- ADVB 9.7M
- BOLT 11.5M
- IPO Year
- ADVB 2025
- BOLT 2021
- Fundamental
- Price
- ADVB $0.42
- BOLT $5.05
- Analyst Decision
- ADVB
- BOLT Buy
- Analyst Count
- ADVB 0
- BOLT 4
- Target Price
- ADVB N/A
- BOLT $34.00
- AVG Volume (30 Days)
- ADVB 1.7M
- BOLT 34.2K
- Earning Date
- ADVB 11-19-2025
- BOLT 11-12-2025
- Dividend Yield
- ADVB N/A
- BOLT N/A
- EPS Growth
- ADVB N/A
- BOLT N/A
- EPS
- ADVB N/A
- BOLT N/A
- Revenue
- ADVB N/A
- BOLT $5,195,000.00
- Revenue This Year
- ADVB N/A
- BOLT N/A
- Revenue Next Year
- ADVB N/A
- BOLT N/A
- P/E Ratio
- ADVB N/A
- BOLT N/A
- Revenue Growth
- ADVB N/A
- BOLT N/A
- 52 Week Low
- ADVB $0.34
- BOLT $4.41
- 52 Week High
- ADVB $4.10
- BOLT $13.00
- Technical
- Relative Strength Index (RSI)
- ADVB 47.63
- BOLT 50.64
- Support Level
- ADVB $0.36
- BOLT $4.66
- Resistance Level
- ADVB $0.49
- BOLT $5.14
- Average True Range (ATR)
- ADVB 0.04
- BOLT 0.28
- MACD
- ADVB -0.00
- BOLT 0.06
- Stochastic Oscillator
- ADVB 44.36
- BOLT 93.15
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.